We also found decreased levels of N-acetylmethionine (NAM) in carriers of the PNPLA3 variant having NAFLD, similarly as has been published for patients with NASH [28]. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatohepatitis.